NORGINE BV has a total of 338 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 1999. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are HEMAQUEST PHARMACEUTICALS INC, HOERRMANN WILHELM and CHO DANG PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 57 | |
#2 | United States | 30 | |
#3 | EPO (European Patent Office) | 27 | |
#4 | Australia | 22 | |
#5 | WIPO (World Intellectual Property Organization) | 17 | |
#6 | China | 15 | |
#7 | Republic of Korea | 14 | |
#8 | Canada | 11 | |
#9 | New Zealand | 11 | |
#10 | South Africa | 11 | |
#11 | Brazil | 8 | |
#12 | Singapore | 8 | |
#13 | Argentina | 7 | |
#14 | EAPO (Eurasian Patent Organization) | 7 | |
#15 | Japan | 7 | |
#16 | Mexico | 7 | |
#17 | Netherlands | 7 | |
#18 | Hong Kong | 6 | |
#19 | Italy | 6 | |
#20 | Taiwan | 6 | |
#21 | Belgium | 5 | |
#22 | Spain | 5 | |
#23 | France | 5 | |
#24 | Ireland | 5 | |
#25 | Malaysia | 5 | |
#26 | Hungary | 4 | |
#27 | Serbia | 4 | |
#28 | Israel | 3 | |
#29 | Ukraine | 3 | |
#30 | India | 2 | |
#31 | Luxembourg | 2 | |
#32 | Montenegro | 2 | |
#33 | Tunisia | 2 | |
#34 | Austria | 1 | |
#35 | Germany | 1 | |
#36 | Denmark | 1 | |
#37 | Norway | 1 | |
#38 | Poland | 1 | |
#39 | Sweden | 1 | |
#40 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Stein Peter | 118 |
#2 | Cox Ian | 98 |
#3 | Cockett Alasdair | 94 |
#4 | Halphen Marc | 88 |
#5 | Ungar Alex | 88 |
#6 | Jones Leighton | 84 |
#7 | Padfield Dawn | 51 |
#8 | Davidson Ian | 43 |
#9 | Worthington Jeffrey | 43 |
#10 | Farrag Lynn | 43 |
Publication | Filing date | Title |
---|---|---|
JP2019172706A | Method for washing colon | |
AU2019287097A1 | Pharmaceutical composition for treating chronic constipation | |
AU2015228962A1 | Method of cleansing the colon | |
EP3087074A1 | Benzene sulfonamides as ccr9 inhibitors | |
US2017001959A1 | Compounds useful as CCR9 modulators | |
WO2014066745A1 | Compositions comprising polyethylene glycol in the therapy of head and neck squamous cell carcinoma | |
IES20130273A2 | Compositions comprising PEG and ascorbate | |
AU2013314442A1 | Compositions comprising PEG and ascorbate | |
GB201312851D0 | Pharmaceutical compositions | |
ZA201304053B | Formulations comprising polyethylene glycol | |
TN2013000172A1 | Formulations comprising polyethylene glycol | |
TN2013000173A1 | Peg or peg block copolymers for treating colorectal cancer | |
WO2013092786A1 | Compositions comprising cetilistat | |
AU2012101841A4 | Compositions comprising cetilistat | |
GB201217918D0 | Prognostic method | |
GB201217917D0 | Solutions | |
GB201217919D0 | Prognostic method | |
GB201213303D0 | Pharmaceutical compositions | |
GB201204102D0 | Compositions | |
GB201204103D0 | Compositions |